Based on the inclusion criteria for this review, two papers identified leptin measurement as a useful breast cancer inflammatory biomarker, particularly in relation to exercise (88) or loss of body fat (64), and the potential for these two factors to decrease of leptin levels, resulting in improved the disease outcome. This evidence concerns the gene LEP and breast carcinoma.